King Faisal Specialist Hospital & Research Centre (KFSHRC) in Jeddah has completed the first robotic liver transplant in the Western Region.
The transplant was performed on a 23-year-old man suffering from hereditary chronic progressive liver disease.
This milestone will help KFSHRC in providing better healthcare and patient care.
King Faisal Specialist Hospital & Research Centre offers a comprehensive environment focused on education, research, and specialised treatments.
The procedure involved the complete use of robotic technology, with no direct human intervention in both donor liver removal and transplant surgery.
It was carried out in collaboration with the liver transplant team at KFSHRC Riyadh, ensuring enhanced precision, reduced recovery time, and minimised risk of complications.
After the procedure, both the donor and recipient were discharged in good health, showcasing the efficiency of the Jeddah organ transplant programme in handling complex cases.
KFSHRC also plans to perform two liver transplant surgeries per month, expanding the programme’s capacity to serve more patients.
The hospital is continuously advancing robotic surgery in the Western Region.
In 2023, it announced the first-ever fully robotic liver transplant, followed by 31 more procedures, solidifying its technical and surgical expertise in this advanced field.
This year, KFSHRC announced the world’s first fully robotic heart transplant and the first fully robotic liver transplant from a living donor using the left lobe.
Last month, King Faisal Specialist Hospital & Research Centre in Madinah announced the use of Large-Format Tissue Processing (Supa Mega Block) technology. This method speeds up the examination of cancerous tissues post-removal, ensuring complete excision in one step.
The technology offers time savings, cost reduction, and an improved patient experience, making KFSHRC-Madinah the first in Saudi Arabia to implement this advanced approach.
In the same month, KFSHRC and Eli Lilly Saudi Arabia signed a Memorandum of Understanding (MoU) to boost Alzheimer’s patient care and early detection.
